Your browser is no longer supported. Please, upgrade your browser.
Zynex, Inc.
Index- P/E60.77 EPS (ttm)0.30 Insider Own40.20% Shs Outstand34.49M Perf Week33.21%
Market Cap627.78M Forward P/E38.08 EPS next Y0.47 Insider Trans0.02% Shs Float19.46M Perf Month30.14%
Income10.20M PEG- EPS next Q0.06 Inst Own35.60% Short Float31.38% Perf Quarter28.38%
Sales68.70M P/S9.14 EPS this Y-0.40% Inst Trans-1.24% Short Ratio11.34 Perf Half Y-19.97%
Book/sh1.57 P/B11.50 EPS next Y75.56% ROA25.10% Target Price25.75 Perf Year68.85%
Cash/sh1.18 P/C15.24 EPS next 5Y- ROE32.90% 52W Range7.93 - 29.73 Perf YTD34.10%
Dividend- P/FCF165.20 EPS past 5Y27.80% ROI43.50% 52W High-39.28% Beta0.89
Dividend %- Quick Ratio7.10 Sales past 5Y32.50% Gross Margin78.80% 52W Low127.62% ATR0.98
Employees283 Current Ratio7.90 Sales Q/Q69.50% Oper. Margin17.00% RSI (14)71.55 Volatility7.52% 6.26%
OptionableYes Debt/Eq0.01 EPS Q/Q-37.00% Profit Margin14.90% Rel Volume1.11 Prev Close16.52
ShortableYes LT Debt/Eq0.00 EarningsOct 27 AMC Payout0.00% Avg Volume538.16K Price18.05
Recom1.80 SMA2026.40% SMA5030.13% SMA2006.14% Volume596,627 Change9.26%
Sep-14-20Upgrade H.C. Wainwright Neutral → Buy $25
Sep-09-20Upgrade Northland Capital Market Perform → Outperform $22.50
Jul-29-20Upgrade B. Riley FBR Neutral → Buy $28
Jul-20-20Initiated Piper Sandler Overweight $30
Jul-13-20Downgrade B. Riley FBR Buy → Neutral
Jul-10-20Reiterated H.C. Wainwright Neutral $20 → $30
Jun-16-20Downgrade Northland Capital Outperform → Market Perform
May-19-20Downgrade H.C. Wainwright Buy → Neutral $20
Apr-01-20Initiated Northland Capital Outperform $15
Sep-23-19Initiated H.C. Wainwright Buy $12
Jan-14-21 09:15AM  
Jan-12-21 09:00AM  
Jan-06-21 09:15AM  
Dec-31-20 04:11AM  
Dec-30-20 05:00AM  
Dec-10-20 09:40PM  
Dec-01-20 05:34AM  
Nov-19-20 09:15AM  
Nov-17-20 09:15AM  
Oct-29-20 03:07PM  
Oct-27-20 08:31PM  
Oct-23-20 09:15AM  
Oct-20-20 09:15AM  
Oct-13-20 02:38AM  
Oct-12-20 11:35AM  
Oct-06-20 09:15AM  
Sep-23-20 02:42PM  
Sep-14-20 10:16AM  
Sep-10-20 09:00AM  
Sep-04-20 12:01PM  
Sep-03-20 09:00AM  
Aug-26-20 12:27PM  
Aug-16-20 06:22AM  
Aug-05-20 08:20AM  
Jul-28-20 11:31PM  
Jul-27-20 11:10AM  
Jul-24-20 09:37PM  
Jul-23-20 09:21AM  
Jul-16-20 03:14PM  
Jul-15-20 11:37AM  
Jul-14-20 11:43PM  
Jul-10-20 12:46PM  
Jul-09-20 09:15AM  
Jun-15-20 02:46PM  
Jun-14-20 08:08PM  
Jun-12-20 09:59AM  
Jun-10-20 05:51PM  
Jun-09-20 11:29AM  
May-21-20 10:59AM  
May-18-20 09:11AM  
May-14-20 03:45PM  
May-13-20 11:29AM  
May-12-20 04:20PM  
May-05-20 10:55AM  
May-04-20 08:11AM  
Apr-29-20 02:01AM  
Apr-28-20 04:02PM  
Apr-21-20 09:20AM  
Apr-17-20 11:41AM  
Apr-13-20 12:14PM  
Apr-07-20 09:24AM  
Apr-02-20 08:27AM  
Mar-30-20 09:15AM  
Mar-18-20 08:59PM  
Mar-02-20 01:01PM  
Feb-28-20 07:28AM  
Feb-27-20 04:02PM  
Feb-25-20 11:22AM  
Feb-21-20 12:38PM  
Feb-18-20 09:24AM  
Feb-03-20 09:20AM  
Jan-29-20 08:24AM  
Jan-23-20 12:47PM  
Jan-16-20 08:55AM  
Jan-09-20 09:11AM  
Jan-07-20 09:22AM  
Dec-22-19 04:43PM  
Dec-02-19 09:22AM  
Nov-14-19 09:21AM  
Nov-06-19 01:24PM  
Nov-01-19 09:35PM  
Oct-29-19 04:01PM  
Oct-17-19 09:20AM  
Oct-12-19 09:55AM  
Oct-11-19 01:55PM  
Oct-04-19 12:11PM  
Oct-02-19 09:16AM  
Sep-24-19 11:00AM  
Sep-19-19 11:18AM  
Sep-06-19 02:48PM  
Aug-28-19 04:40PM  
Aug-21-19 10:21AM  
Aug-19-19 10:15PM  
Aug-16-19 11:15AM  
Aug-06-19 02:00AM  
Aug-05-19 06:20AM  
Jul-31-19 10:48PM  
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MOORHEAD DANIEL JChief Financial OfficerJul 30Buy18.112,73349,49519,001Jul 30 09:36 PM
Sandgaard ThomasPresident, CEO and ChairmanJul 14Sale22.001,250,00027,500,00012,682,000Jul 16 06:33 PM